Agenda – Virtual Clinical Trials Conference

  • Day One
  • Day Two

Day One

 Monday | December 2

9:15AM – 10:00AM

A Stakeholder Perspective on Virtual Clinical Trials
Jan Nissen, Vice President, Patient Innovation & Engagement, Merck

10:00AM – 10:45AM

Review the Evolution of Siteless Trials
Hassan Kadhim, Director, Head of Clinical Trial Business Capabilities, Bristol-Myers Squibb

10:45AM – 11:15AM

Adopt and Implement a VCT Model Within Your Organization: A CNS Case Study
Candace Saldarini, M.D., Director, Applied Innovation and Process Improvement, OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION, INC.

11:15AM – 12:00PM


12:45PM – 1:30PM

Enhance Patient Engagement, Participation, and Retention Through Behavior Change
Nnamdi Ezeanochie, Senior Manager, Behavior Science, JOHNSON AND JOHNSON
Jan Nissen, Vice President, Patient Innovation and Engagement, Merck

1:30PM – 2:30PM


2:30PM – 3:30PM

How Virtual (Decentralized Clinical) Trials Could Improve Safety Monitoring and Improve Patient Follow-up During a Trial for Diagnostics and Devices
Brittany Goldberg, M.D., Medical Officer, FDA
Alka Shaunik, M.D., Senior Medical Director, Global Medical Affairs, SANOFI
Matthew Moyer, M.S., MBA, PMP, Director, Clinical Supply Technology, Merck

3:30PM – 4:00PM


4:00PM – 4:45PM

Logistics, Pitfalls, and What to Look for As You Begin on VCTs
Michael Sparozic, Operation Manager and Leader, Trial Supplies, SANOFI

4:45PM –


Day Two

 Tuesday | December 3

8:30AM – 9:30AM

Continental Breakfast

9:45AM – 10:30AM

Selecting the Right Digital Tools and Devices for Your Clinical Trial
Michael Song, Head of Device Functionality, Safety, and Digital Connectivity, MEDIMMUNE

10:30AM – 11:15AM

Implement New Technology Into Virtual Clinical Trial Process Flow
Kerensa Saljooqi, Associate Director, Clinical Operations, BLACKTHORN THERAPEUTICS
Maria Palombini, Director, Communities and Initiatives Development, Emerging Technology, IEEE Standards Association

11:15AM – 11:45AM


11:45AM – 12:45PM

TransCelerate Patient Technology: Enabling and Accelerating Use of Patient-Facing Technologies to Benefit All Clinical Trial Stakeholders
Matthew Moyer, M.S., MBA, PMP, Director, Clinical Supply Technology, Merck

12:45PM – 1:45PM


1:45PM – 2:30PM

Coming to You Live From a Virtual Randomized Registration Trial for a Digital Therapeutic
Dr. Daniel Karlin, Chief Medical Officer, NIGHTWARE; Chair, Advisory Board, DIME SOCIETY

2:30PM – 3:15PM

FDA Presents on Clinical Trial Innovation to Break Down the Current Regulatory Landscape
Isaac R. Rodriguez-Chavez, Ph.D., MH.Sc., M.Sc., FDA Officer, Clinical Research Methodology, Regulatory Compliance and Policy Development, FDA/CDER

3:15PM – 4:00PM

Deep Dive Into Legal Issues That Arise During Virtual and Hybrid Trials
Bradley Davidson, Legal Counsel, Clinical R&D, ABBVIE